Company intelligence / Profile preview

Schiapparelli

Ownership: Private
Development stage: Other

Overview

Schiapparelli was a long-standing provider of automated centrifugal analysis instruments and diagnostic kits for clinical laboratories. It developed notable products such as the KII Ultracentrifuge, used in virus isolation for vaccine production, and a range of chemistry analyzers. The company exited the diagnostics business in the late 1990s after being acquired by Alfa Wassermann.

Therapeutic areas: Infectious DiseasesOther
Modalities: DeviceDiagnostic kit
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Schiapparelli.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Schiapparelli.

Explore the full profile